SUBSCRIBE
SUBSCRIBE
News   FDA

Pfizer Inc.'s (JOBS) Bone-Drug Fablyn Fails to Win U.S. Approval

January 17, 2009 | 
1 min read
Jan. 16 (Bloomberg) -- Pfizer Inc., the world’s largest drugmaker, failed to win U.S. approval to sell a treatment for women with weak bones that may be linked to an increase in deaths.
FDA Approvals Regulatory
Pfizer
MORE ON THIS TOPIC
Pictured: CDC signage at its headquarters in Georg
CDC
CDC Adopts ACIP Recommendations on Chickenpox, COVID-19 Vaccines
October 6, 2025
 · 
1 min read
 · 
Heather McKenzie
Traffic light silhouette and golden sky.
ALS
FDA Lifts Clinical Hold, Clearing Neurizon’s ALS Drug for Human Trials
October 6, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Manufacturing
FDA Continues US Manufacturing Drive With Domestic Generics Pilot
October 6, 2025
 · 
2 min read
 · 
Tristan Manalac
Space rocket crashed and on fire. Business failure, failed startup. Downfall of ambitious plans, flawed execution, or crisis outcomes. Volatility of startups, financial risks, or unexpected setbacks.
Gene therapy
Rocket Aborts FDA Filing for Rare Blood Disease Gene Therapy
October 6, 2025
 · 
2 min read
 · 
Tristan Manalac